{"transactions":[{"id":1255231,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T22:27:36.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from February 18, 2025, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after the termination of service."}],"balance_after":3000000,"derivative":{"exercise_price":0.0375,"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0000950170-25-024328","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000095017025024328/ownership.xml","form_type":"4"}},{"id":1470400,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-24T21:25:56.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from June 20, 2024, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service."}],"balance_after":3000000,"derivative":{"exercise_price":0.054,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0000950170-24-076906","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000095017024076906/ownership.xml","form_type":"4"}},{"id":1946116,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-17T20:44:55.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from March 15, 2023, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service."}],"balance_after":2500000,"derivative":{"exercise_price":0.04,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001510964-23-000009","document":"wf-form4_167908588567379.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096423000009/wf-form4_167908588567379.xml","form_type":"4"}},{"id":2310824,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is performance-based. 250,000 option shares were vested and exercisable on the date of cancellation. The remaining option shares were scheduled to vest and become exercisable in accordance with certain performance criteria which were not met at the date of cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.365,"expiration_date":"2027-04-06","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2310823,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is performance-based. 500,000 option shares were vested and exercisable on the date of cancellation. The remaining option shares were scheduled to vest and become exercisable in accordance with certain performance criteria which were not met at the date of cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.368,"expiration_date":"2026-07-05","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2310822,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":600000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational based. All option shares were vested and exercisable on the date of cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.38,"expiration_date":"2024-09-30","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2310821,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational based. All option shares were vested and exercisable on the date of cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.38,"expiration_date":"2025-05-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2310820,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational based. All option shares were vested and exercisable on the date of cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.73,"expiration_date":"2015-09-22","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2310819,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was fully vested on the date of grant."}],"balance_after":0,"derivative":{"exercise_price":0.38,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2310818,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-03-20","expiration_date":"2028-03-19","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2310817,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational based. All option shares were vested and exercisable on the date of cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.66,"expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2310816,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":1500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is durational based. 750,000 option shares were vested and exercisable on the date of cancellation. Twenty-five (25%) of the option shares were scheduled to vest and become exercisable on September 1, 2022 and March 1, 2023, provided, that there was no termination of service as of such date."}],"balance_after":0,"derivative":{"exercise_price":0.59,"expiration_date":"2031-03-08","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2310815,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-02T00:15:40.000Z","date":"2022-03-30","kind":"disposition_to_issuer","acquired":false,"shares":1500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational based. All option shares were vested and exercisable on the date of cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.33,"expiration_date":"2030-03-19","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001510964-22-000026","document":"wf-form4_164885852291255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000026/wf-form4_164885852291255.xml","form_type":"4"}},{"id":2794171,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-11T22:01:03.000Z","date":"2021-03-09","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational-based. No option shares are vested on the date of grant. Twenty-five percent (25%) of the option shares vest and become exercisable on each of the following dates: September 1, 2021, March 1, 2022, September 1, 2022, and March 1, 2023, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service."}],"balance_after":1500000,"derivative":{"exercise_price":0.59,"expiration_date":"2031-03-08","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001510964-21-000006","document":"wf-form4_161550003123434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096421000006/wf-form4_161550003123434.xml","form_type":"4"}},{"id":3196227,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-25T01:50:39.000Z","date":"2020-03-20","kind":"grant","acquired":true,"shares":1500000,"price":0.33,"value":495000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational-based. 500,000 option shares vested on the grant date, 500,000 option shares vest and become exercisable on April 15, 2020 and the remaining 500,000 option shares vest and become exercisable on July 15, 2020, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service."}],"balance_after":1500000,"derivative":{"exercise_price":0.33,"expiration_date":"2030-03-19","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001510964-20-000016","document":"wf-form4_158510102097096.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096420000016/wf-form4_158510102097096.xml","form_type":"4"}},{"id":3200279,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-19T22:59:49.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational-based. 250,000 option shares vested on the date of grant and the remaining 250,000 option shares vest and become exercisable on May 20, 2019, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service."}],"balance_after":500000,"derivative":{"exercise_price":4.72,"expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001510964-20-000012","document":"wf-form4_158465877181784.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096420000012/wf-form4_158465877181784.xml","form_type":"4"}},{"id":3374070,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-11-12T21:05:11.000Z","date":"2019-11-08","kind":"purchase","acquired":true,"shares":15000,"price":1.65,"value":24750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions at a price of $1.65 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person undertakes to provide CV Sciences, Inc., any security holder of CV Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares purchased at the price set forth in footnote (1) to this Form 4."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001510964-19-000074","document":"wf-form4_157359269572210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096419000074/wf-form4_157359269572210.xml","form_type":"4"}},{"id":3942253,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-09T00:26:42.000Z","date":"2018-03-20","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The stock options are fully-vested on the Date of Grant."}],"balance_after":500000,"derivative":{"exercise_price":0.4,"exercise_date":"2018-03-20","expiration_date":"2028-03-19","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001683168-18-001235","document":"dowling_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000168316818001235/dowling_f4.xml","form_type":"4"}},{"id":3980682,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-28T12:01:10.000Z","date":"2017-07-14","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On April 7, 2017, the Reporting Person was granted an option to purchase 1,000,000 shares of the Issuer's Common Stock. The option is performance-based, and vests and becomes exercisable as follows: (i) when the Company has final meeting minutes from a pre-IND meeting as authorized by the FDA for a drug development program utilizing CBD as the active pharmaceutical ingredient (25% vesting of the shares subject to the option); (ii) when the Company is granted an IND (25% vesting of the shares subject to the option); and (iii) when the Company commences its first human dosing under the IND (50% vesting of the shares subject to the option). On July 14, 2017, the first performance criterion was met resulting in vesting of the option as to 250,000 shares."}],"balance_after":250000,"derivative":{"exercise_price":0.365,"exercise_date":"2017-07-14","expiration_date":"2027-04-06","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001683168-18-000770","document":"dowling_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000168316818000770/dowling_f4.xml","form_type":"4"}},{"id":3980681,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-28T12:01:10.000Z","date":"2017-07-14","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On July 6, 2016, the Reporting Person was granted an option to purchase 1,000,000 shares of the Issuer's Common Stock. The option is performance-based, and vests and becomes exercisable as follows: (i) the first time the Issuer completes development of a U.S. Food & Drug Administration (\"FDA\") current good manufacturing practice grade batch of successfully synthetically formulated Cannabidiol (\"CBD\") for use in drug development activities (25% vesting of the shares subject to the option); (ii) when the Company has final meeting minutes from a pre-investigational new drug application (\"IND\") meeting as authorized by the FDA for a drug development program utilizing CBD as the active pharmaceutical ingredient (25% vesting of the shares subject to the option); (iii) when the Company is granted an IND (25% vesting of the shares subject to the option); and (iv) when the Company commences its first human dosing under the IND (25% vesting of the shares subject to the option)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On July 14, 2017, the second performance criterion was met resulting in vesting of the option as to 250,000 shares."}],"balance_after":250000,"derivative":{"exercise_price":0.368,"exercise_date":"2017-07-14","expiration_date":"2026-07-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001683168-18-000770","document":"dowling_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000168316818000770/dowling_f4.xml","form_type":"4"}},{"id":4367818,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-30T21:01:11.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested on the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":0.38,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001144204-17-017748","document":"v462987_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000114420417017748/v462987_4.xml","form_type":"4"}},{"id":4578894,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":82966,"kind":"person","name":"Dowling Joseph D","position":1,"cik":"0001611860","reported_name":"Dowling Joseph D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-10-17T22:32:42.000Z","date":"2016-10-05","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"See remarks below."}],"balance_after":250000,"derivative":{"exercise_price":0.368,"exercise_date":"2016-10-05","expiration_date":"2026-07-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001683168-16-000331","document":"dowling_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510964/000168316816000331/dowling_frm4.xml","form_type":"4"}}]}